[go: up one dir, main page]

CN113730033B - Sealing member for prosthetic heart valve - Google Patents

Sealing member for prosthetic heart valve Download PDF

Info

Publication number
CN113730033B
CN113730033B CN202111060324.0A CN202111060324A CN113730033B CN 113730033 B CN113730033 B CN 113730033B CN 202111060324 A CN202111060324 A CN 202111060324A CN 113730033 B CN113730033 B CN 113730033B
Authority
CN
China
Prior art keywords
frame
skirt
tether
segment
prosthetic valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111060324.0A
Other languages
Chinese (zh)
Other versions
CN113730033A (en
Inventor
T·S·列维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Priority to CN202111060324.0A priority Critical patent/CN113730033B/en
Publication of CN113730033A publication Critical patent/CN113730033A/en
Application granted granted Critical
Publication of CN113730033B publication Critical patent/CN113730033B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409Support rings therefor, e.g. for connecting valves to tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • A61F2/2433Deployment by mechanical expansion using balloon catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/001Figure-8-shaped, e.g. hourglass-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0019Angular shapes rectangular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0069Sealing means

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

本申请涉及用于人工心脏瓣膜的密封构件。一种可植入的人工瓣膜能够包括:环形框架,包括流入端和流出端,并且在径向收缩构造与径向扩张构造之间可径向收缩和扩张,该框架限定从流入端延伸到流出端的轴向方向;小叶结构,定位在框架内并固定到其上;以及外部密封构件,定位在框架的外表面周围,其中外部密封构件包括多个密封段,其中每个密封段通过系绳联接到框架和/或另一个密封段,该系绳在框架径向扩张到扩张构造时沿周向方向拉动密封段的一部分。

The present application relates to a sealing member for an artificial heart valve. An implantable artificial valve can include: an annular frame including an inflow end and an outflow end, and radially contractible and expandable between a radially contracted configuration and a radially expanded configuration, the frame defining an axial direction extending from the inflow end to the outflow end; a leaflet structure positioned within the frame and fixed thereto; and an external sealing member positioned around an outer surface of the frame, wherein the external sealing member includes a plurality of sealing segments, wherein each sealing segment is coupled to the frame and/or another sealing segment by a tether, and the tether pulls a portion of the sealing segment in a circumferential direction when the frame is radially expanded to the expanded configuration.

Description

Sealing member for prosthetic heart valve
The present application is a divisional application of chinese patent application 2018800639632 (PCT/US 2018/047071) entitled "sealing member for prosthetic heart valve" filed on 8/20 of 2018.
Technical Field
The present disclosure relates to implantable, expandable prosthetic devices (prosthetic device) and methods and apparatus for such prosthetic devices.
Background
The human heart may suffer from various valve diseases. These valve diseases can lead to serious dysfunction of the heart, ultimately requiring replacement of the native valve with a prosthetic valve. There are many known prosthetic valves and many known methods of implanting these prosthetic valves into the human body. Percutaneous and minimally invasive surgical methods are receiving considerable attention due to the shortcomings of conventional open-heart surgery. In one technique, a prosthetic valve (prosthetic valve) is configured to be implanted in a much less invasive manner by catheterization. For example, a collapsible (collapsible ) transcatheter prosthetic heart valve may be crimped to a compressed state and introduced percutaneously into the catheter in the compressed state and expanded to a functional size at a desired location by balloon inflation or with a self-expanding frame or stent.
Prosthetic valves used in such procedures may include a radially collapsible and expandable frame to which the leaflets of the prosthetic valve may be coupled and which may be introduced percutaneously over a catheter in a collapsed configuration and inflated by a balloon or expanded at a desired location with a self-expanding frame or stent. One challenge faced by prosthetic valves implanted in catheters is controlling paravalvular leakage around the valve, which may occur over a period of time following initial implantation. Another challenge includes a process of crimping such prosthetic valves into a profile suitable for percutaneous delivery to a patient.
Disclosure of Invention
Disclosed herein are embodiments of radially contractible and expandable prosthetic valves, including improved outer skirts for reducing paravalvular leakage, and related methods and apparatus including such prosthetic valves. In several embodiments, the disclosed prosthetic valves are configured as replacement heart valves for implantation in a patient.
In one representative embodiment, an implantable prosthetic valve can include an annular frame, a leaflet structure positioned within and secured to the frame, and an annular outer skirt positioned about an outer surface of the frame. The frame may include an inflow end and an outflow end, and may be radially contracted and expanded between a radially contracted configuration and a radially expanded configuration. The frame may define an axial direction extending from the inflow end to the outflow end. The outer skirt may include an inflow edge portion secured to the frame at a first location, an outflow edge portion secured to the frame at a second location, an intermediate portion between the inflow edge portion and the outflow edge portion, and a plurality of tethers. The intermediate portion may include a plurality of circumferentially spaced axially extending slits defining a plurality of skirt segments between each pair of slits, each skirt segment may include first and second opposed edge portions. Each tether may be secured to a first edge portion of a skirt segment at a first end of the tether, may extend through a second edge portion of the same skirt segment, and may be secured to the frame or an adjacent skirt segment at a second end of the tether such that the first edge portion is pulled by the tether in a circumferential direction toward the second portion when the frame expands to a radially expanded configuration.
In some embodiments, the second end of each tether may be secured to the frame.
In some embodiments, the second end of each tether may be secured to the frame adjacent the second edge portion of the skirt segment to which the first end of the tether is secured.
In some embodiments, the frame may include a plurality of struts, and the second end of each tether may be secured to the frame at the struts adjacent the second edge portion of the skirt section to which the first end of the tether is secured.
In some embodiments, each tether may be positioned radially outward of the skirt segment.
In some embodiments, each tether may be positioned radially inside the skirt segment.
In some embodiments, the tethers may include a first set of tethers positioned radially outward of the skirt segments and a second set of tethers positioned radially inward of the skirt segments.
In some embodiments, the tether may include a plurality of first tethers and a plurality of second tethers. In such embodiments, each first tether may have a first end secured to a first edge portion of a respective skirt segment, may extend through a second edge portion of the same skirt segment, and may have a second end secured to the frame at a first location. In such embodiments, each second tether may have a first end secured to the second edge portion of the respective skirt segment, may extend through the first edge portion of the same skirt segment, and may have a second end secured to the frame at a second location. In such embodiments, the first and second positions may be adjacent opposite sides of the skirt segment such that when the frame expands to the radially expanded configuration, the second tether pulls the second edge portion toward the first edge portion and the first tether pulls the first edge portion toward the second edge portion.
In some embodiments, the first tether may be positioned radially outside of the outer skirt and the second tether may be positioned radially inside of the outer skirt.
In some embodiments, the first tether and the second tether may each be positioned radially outward of the outer skirt.
In some embodiments, the first tether and the second tether may each be positioned radially inward of the outer skirt.
In some embodiments, the second end of each tether may be secured to an adjacent skirt segment.
In some embodiments, the plurality of tethers may include a plurality of first tethers and a plurality of second tethers. In such embodiments, each skirt segment may be coupled to a first adjacent skirt segment by a respective first tether and to a second adjacent skirt segment by a respective second tether such that when the frame expands to the radially expanded configuration, the first and second tethers pull the first and second edge portions of the skirt segments toward each other.
In some embodiments, for each skirt segment, a first tether may extend from a first edge portion of the skirt segment through a second edge portion and may be secured to a first adjacent skirt segment, and a second tether may extend from a second edge portion of the skirt segment through the first edge portion and may be secured to a second adjacent skirt segment.
In some embodiments, the first plurality of tethers may be positioned radially inward of the outer skirt and the second plurality of tethers may be positioned radially outward of the outer skirt.
In another representative embodiment, an implantable prosthetic valve can include an annular frame, a leaflet structure positioned within and secured to the frame, and an outer sealing member positioned about an outer surface of the frame. The frame may include an inflow end and an outflow end, and may be radially contractible and expandable between a radially contracted configuration and a radially expanded configuration. The frame may define an axial direction extending from the inflow end to the outflow end. The outer sealing member may comprise a plurality of sealing segments. Each seal segment may be coupled to the frame and/or another seal segment by a tether that pulls a portion of the seal segment in a circumferential direction as the frame radially expands to the expanded configuration.
In some embodiments, each seal segment may have upper and lower portions connected to the frame at axially spaced locations on the frame, the upper and lower portions moving toward each other upon radial expansion of the frame and causing a portion of the seal segment to move radially outward away from the frame.
In some embodiments, the width of each seal segment in the circumferential direction may be reduced by the tension of a tether attached to the seal segment as the frame radially expands.
In some embodiments, each seal segment may be at least partially twisted by the tension of a tether attached to the seal segment as the frame radially expands.
In some embodiments, each tether may have one end secured to a seal segment and another end secured to a frame or another seal segment.
The foregoing and other objects, features, and advantages of the present disclosure will become more apparent from the following detailed description, which proceeds with reference to the accompanying drawings.
Drawings
Fig. 1-3 illustrate an exemplary embodiment of a prosthetic heart valve.
Fig. 4-10 illustrate an exemplary frame of the prosthetic heart valve of fig. 1.
Fig. 11-12 illustrate an exemplary inner skirt of the prosthetic heart valve of fig. 1.
Fig. 13 shows the prosthetic heart valve of fig. 1 in a contracted configuration and mounted on an exemplary balloon catheter.
Fig. 14-16 illustrate the assembly of the inner skirt of fig. 11 with the frame of fig. 4.
Figures 17-18 illustrate components of an exemplary leaflet structure.
Figure 19 shows an assembly of a commissure portion of a leaflet structure with a window frame portion of a frame.
Figures 20-21 illustrate the assembly of the leaflet structure with the inner skirt along the lower edge of the leaflet.
Fig. 22-23 illustrate various views of another exemplary outer skirt.
Fig. 24-25 illustrate an exemplary embodiment of a prosthetic heart valve frame using the outer skirt of fig. 22-23.
Fig. 26-27 illustrate another exemplary embodiment of a prosthetic heart valve frame using the outer skirt of fig. 22-23.
Fig. 28-29 illustrate another exemplary embodiment of a prosthetic heart valve frame using the outer skirt of fig. 22-23.
Fig. 30 shows an exemplary prosthetic heart valve implanted in a native aortic valve of a patient.
Fig. 31 shows an exemplary prosthetic heart valve and docking device implanted in a patient's pulmonary artery.
Fig. 32 illustrates an exemplary prosthetic heart valve and docking device implanted in a native mitral valve of a patient.
Fig. 33-34 illustrate an alternative embodiment of a docking device for a prosthetic valve.
Fig. 35 illustrates an exemplary prosthetic heart valve and the docking device of fig. 33-34.
Detailed Description
Fig. 1-3 illustrate various views of a prosthetic heart valve 10 according to one embodiment. The prosthetic valve shown is suitable for implantation in a native aortic annulus, although in other embodiments it may be suitable for implantation in other native annuluses of the heart (e.g., pulmonary, mitral, and tricuspid). The prosthetic valve may also be adapted for implantation into other tubular organs or passages within the body. The prosthetic valve 10 can have four main components: a stent or frame 12, a valve structure 14, an inner skirt 16, and a paravalvular sealing device or sealing member. The prosthetic valve 10 can have an inflow end portion 15, a middle portion 17, and an outflow end portion 19. In the illustrated embodiment, the paravalvular sealing device includes an outer skirt 18 (which may also be referred to as an outer sealing member).
The valve structure 14 may include three leaflets 41 that together form a leaflet structure, which may be arranged as a collapse in a tricuspid arrangement, as best shown in fig. 2. The lower edge of the leaflet structure 14 desirably has a wavy, curved scalloped shape (the sutures 154 shown in fig. 21 follow the scalloped shape of the leaflet structure). By forming the leaflets with such a scalloped geometry, the stress on the leaflets is reduced, which in turn improves the durability of the prosthetic valve. Furthermore, due to the fan shape, folds and waves at the abdomen of each leaflet (central region of each leaflet) which would lead to early calcification of these regions can be eliminated or at least minimized. The scalloped geometry also reduces the amount of tissue material used to form the leaflet structure, thereby allowing for a smaller, more uniform crimping profile to be formed at the inflow end of the prosthetic valve. The leaflets 41 can be formed of pericardial tissue (e.g., bovine pericardial tissue), biocompatible synthetic material, or various other suitable natural or synthetic materials known in the art and described in U.S. patent No.6,730,118.
The bare frame 12 is shown in fig. 4. The frame 12 may be formed with a plurality of circumferentially spaced slots or commissure windows 20 (three in the illustrated embodiment) adapted to connect commissures of the valve structure 14 to the frame, as described in more detail below. The frame 12 may be made of any of a variety of suitable plastically-expandable materials (e.g., stainless steel, etc.) or self-expanding materials (e.g., nickel titanium alloy (NiTi), such as nitinol). When constructed of a plastically-expandable material, the frame 12 (and thus the prosthetic valve 10) may be crimped into a radially-contracted configuration over the delivery catheter and then expanded within the patient by an inflatable balloon or equivalent expansion mechanism. When constructed from a self-expanding material, the frame 12 (and thus the prosthetic valve 10) may be crimped into a radially contracted configuration and constrained in the contracted configuration by insertion into a sheath or equivalent mechanism of a delivery catheter. Once inside the body, the prosthetic valve can be advanced in and out of the delivery sheath, which allows the prosthetic valve to expand to its functional size.
Suitable plastically-expandable materials that may be used to form the frame 12 include, but are not limited to, stainless steel, biocompatible high strength alloys (e.g., cobalt-chromium alloys or nickel-cobalt-chromium alloys), polymers, or combinations thereof. In particular embodiments, the frame 12 is made of a nickel cobalt chromium molybdenum alloy, such asAlloy (SPS technologies, inc. of Zhenjin, pa.) which corresponds to UNS R30035 alloy (covered by ASTMF 562-02). /(I)The alloy/UNSR 30035 alloy contained by weight 35% nickel, 35% cobalt, 20% chromium and 10% molybdenum. WhenWhen the alloy is used as a frame material, less material is required to achieve the same or better radial and compressive forces, fatigue and corrosion resistance properties than stainless steel. In addition, because less material is required, the crimped profile of the frame may be reduced, thereby providing a lower profile prosthetic valve assembly for percutaneous delivery to a treatment site within the body.
Referring to fig. 4 and 5, the frame 12 in the illustrated embodiment includes: the angled struts 22 of the first lower row I are arranged end-to-end and extend circumferentially at the inflow end of the frame; a second row II of circumferentially extending angled struts 24; a third row III of circumferentially extending angled struts 26; a fourth row IV of circumferentially extending angled struts 28; and a fifth row V of circumferentially extending angled struts 32 at the outflow end of the frame. A plurality of substantially straight axially extending struts 34 may be used to interconnect the struts 22 of the first row I with the struts 24 of the second row II. The angled struts 32 of the fifth row V are connected to the angled struts 28 of the fourth row IV by a plurality of axially extending window frame portions 30 (which define the commissure windows 20) and a plurality of axially extending struts 31. Each axial strut 31 and each frame portion 30 extends from a position defined by the intersection of the lower ends of two angled struts 32 to another position defined by the intersection of the upper ends of two angled struts 28. Fig. 6, 7, 8, 9 and 10 are enlarged views of portions of the frame 12 identified by letters A, B, C, D and E, respectively, in fig. 5.
Each commissure window frame portion 30 is connected to a respective commissure of the leaflet structure 14. As shown, each frame portion 30 is secured at its upper and lower ends to adjacent rows of struts to provide a robust construction that enhances fatigue resistance under cyclic loading of the prosthetic valve as compared to cantilevered struts used to support commissures of the leaflet structure. This configuration enables a reduction in the thickness of the frame wall to achieve a smaller crimped diameter of the prosthetic valve. In certain embodiments, the thickness T (FIG. 4) of the frame 12 measured between the inner and outer diameters is about 0.48mm or less.
The struts and frame portions of the frame together define a plurality of open cells of the frame. At the inflow end of the frame 12, the struts 22, 24 and 34 define a lower row of cells defining openings 36. The struts 24, 26 and 28 of the second, third and fourth rows define two intermediate rows of cells defining openings 38. The fourth and fifth rows of struts 28 and 32, together with the frame portion 30 and struts 31, define an upper row of cells defining apertures 40. The openings 40 are relatively large and sized to allow portions of the leaflet structure 14 to protrude or bulge into and/or through the openings 40 when the frame 12 is crimped to minimize the crimping profile.
As best shown in fig. 7, the lower ends of the struts 31 are connected to the two struts 28 at nodes or joints 44, and the upper ends of the struts 31 are connected to the two struts 32 at nodes or joints 46. The post 31 may have a thickness S1 that is less than the thickness S2 of the engagement portions 44, 46. The engagement portions 44, 46 and the engagement portion 64 prevent complete closure of the aperture 40. Fig. 13 shows the prosthetic valve 10 crimped onto a balloon catheter. It can be seen that the geometry of strut 31 and the engagement portions 44, 46 and 64 help to create sufficient space in the aperture 40 in the contracted configuration to allow portions of the prosthetic leaflet to protrude or bulge outwardly through the aperture. This allows the prosthetic valve to be crimped to a relatively small diameter, rather than confining all of the leaflet material within the crimped frame.
The frame 12 is configured to reduce, prevent, or minimize possible over-expansion of the prosthetic valve at a predetermined balloon pressure, particularly at the outflow end portion of the frame supporting the leaflet structure 14. In one aspect, the frame is configured to have relatively large angles 42a, 42b, 42c, 42d, 42e between the struts, as shown in fig. 5. The larger the angle, the greater the force required to open (expand) the frame. Accordingly, the angle between struts of the frame may be selected to limit radial expansion of the frame at a given opening pressure (e.g., inflation pressure of the balloon). In certain embodiments, these angles are at least 110 degrees or greater when the frame is expanded to its functional size, and more specifically, up to about 120 degrees when the frame is expanded to its functional size.
Furthermore, the inflow and outflow ends of the frame are generally more prone to over-expansion than the middle portion of the frame due to the "dog bone" effect of the balloon used to expand the prosthetic valve. To prevent over-expansion of the leaflet structure 14, the leaflet structure is desirably secured to the frame 12 below the upper row of struts 32, as best shown in fig. 1. Thus, in the event that the outflow end of the frame is over-expanded, the leaflet structure is positioned below a level at which over-expansion may occur, thereby protecting the leaflet structure from over-expansion.
In one type of prosthetic valve structure, if the leaflets are attached too close to the distal end of the frame, a portion of the leaflets protrude longitudinally beyond the outflow end of the frame when the prosthetic valve is crimped. If the delivery catheter to which the crimped prosthetic valve is mounted includes a pushing mechanism or stop member that pushes against or abuts the outflow end of the prosthetic valve (e.g., to maintain the position of the crimped prosthetic valve on the delivery catheter), the pushing member or stop member may damage the portion of the exposed leaflets that extend beyond the outflow end of the frame. Another benefit of connecting the leaflets at a location spaced from the outflow end of the frame is that the outflow end of the frame 12, rather than the leaflets 41, are the most proximal component of the prosthetic valve 10 when the prosthetic valve is crimped onto the delivery catheter. Thus, if the delivery catheter includes a pushing mechanism or stop member that pushes against or abuts the outflow end of the prosthetic valve, the pushing mechanism or stop member contacts the outflow end of the frame, rather than the leaflets 41, in order to avoid damage to the leaflets.
Further, as shown in fig. 5, the openings 36 in the lowermost row of openings in the frame are relatively larger than the openings 38 in the middle two rows. This allows the frame to assume an overall conical shape when crimped, i.e. gradually decreasing from a maximum diameter at the outflow end of the prosthetic valve to a minimum diameter at the inflow end of the prosthetic valve. When crimped, the frame 12 may have a region of reduced diameter extending along a portion of the frame adjacent the inflow end of the frame, which generally corresponds to the region of the frame covered by the outer skirt 18. In some embodiments, the reduced diameter area is reduced as compared to the diameter of the upper portion of the frame (not covered by the outer skirt) such that the outer skirt 18 does not increase the overall crimping profile of the prosthetic valve. When the prosthetic valve is deployed, the frame may expand to a generally cylindrical shape as shown in fig. 4. In one example, when crimped, the frame of a 26mm prosthetic valve has a first diameter of 14French at the outflow end of the prosthetic valve and a second diameter of 12French at the inflow end of the prosthetic valve.
The primary function of the inner skirt 16 is to help secure the valve structure 14 to the frame 12 and to help form a good seal between the prosthetic valve and the native annulus by preventing blood from flowing through the open mesh of the frame 12 below the leaflet lower edge. The inner skirt 16 desirably comprises a tough tear resistant material such as polyethylene terephthalate (PET), although a variety of other synthetic or natural materials may be used (e.g., pericardial tissue). The thickness of the skirt is desirably less than about 0.15mm (about 6 mils), desirably less than about 0.1mm (about 4 mils), and even more desirably about 0.05mm (about 2 mils). In certain embodiments, the skirt 16 may have a variable thickness, e.g., the skirt may be thicker at least one edge thereof than at its center. In one embodiment, the skirt 16 may comprise a PET skirt having a thickness of about 0.07mm at its edges and about 0.06mm at its center. Thinner skirts may provide better crimping performance while still providing a good seal.
Skirt 16 may be secured to the interior of frame 12 by sutures 70, as shown in fig. 21. The valve structure 14 may be attached to the skirt by one or more reinforcement bands 72 (which may together form a sleeve) discussed below, such as a thin PET reinforcement band, which enables safe suturing and protects the pericardial tissue of the leaflet structure from tearing. The valve structure 14 may be sandwiched between the skirt 16 and a thin PET tape 72, as shown in fig. 20. The sutures 154 securing the PET tape and leaflet structure 14 to the skirt 16 may be any suitable suture, such as EthibondSuture (Johnson & Johnson, new Brunswick, new Jersey). Suture 154 desirably follows the curvature of the bottom edge of leaflet structure 14, as described in more detail below.
Some fabric skirts include a fabric of warp and weft fibers extending perpendicular to each other, wherein a set of fibers extends longitudinally between the upper and lower edges of the skirt. When a metal frame to which such a fabric skirt is fixed is radially crimped, the overall axial length of the frame increases. However, fabric skirts having limited elasticity cannot elongate with the frame, thus deforming the struts of the frame and preventing uniform crimping.
Referring to fig. 12, in one embodiment, skirt 16 is desirably woven from a first set of fibers or yarns or threads 78 and a second set of fibers or yarns or threads 80, neither of which are perpendicular to upper edge 82 and lower edge 84 of the skirt. In particular embodiments, the first and second sets of fibers 78, 80 extend at an angle of about 45 degrees (e.g., 15-75 degrees or 30-60 degrees) relative to the upper and lower edges 82, 84. For example, the skirt 16 may be formed by braiding fibers at a 45 degree angle relative to the upper and lower edges of the fabric. Alternatively, the skirt 16 may be cut (beveled) diagonally from a vertically woven fabric in which the fibers extend perpendicular to the edges of the material, such that the fibers extend at 45 degrees relative to the cut upper and lower edges of the skirt. As further shown in fig. 12, the relatively short edges 86, 88 of the skirt are desirably non-perpendicular to the upper and lower edges 82, 84. For example, the short edges 86, 88 desirably extend at an angle of about 45 degrees relative to the upper and lower edges and are thus aligned with the first set of fibers 78. Thus, the overall general shape of the skirt may be diamond or parallelogram.
Fig. 14 and 15 show the inner skirt 16 after the opposed short edge portions 90, 92 have been sewn together to form the annular shape of the skirt. As shown, the edge portions 90 may be placed in overlapping relation with respect to the opposing edge portions 92, and the two edge portions may be stitched together with a diagonally extending stitching line 94 parallel to the short edges 86, 88. The upper edge portion of the inner skirt 16 may be formed with a plurality of projections 96 defining a wave-like shape that generally follows the shape or contour of the fourth row of struts 28 immediately below the lower end of the axial struts 31. In this manner, as best shown in fig. 16, the upper edge of the inner skirt 16 may be fixedly secured to the post 28 with a suture 70. The inner skirt 16 may also be formed with slits 98 to facilitate attachment of the skirt to the frame. The slit 98 may be sized to allow the upper edge portion of the inner skirt 16 to wrap partially around the post 28 and reduce stresses in the skirt during attachment. For example, in the illustrated embodiment, the inner skirt 16 is placed inside the frame 12 and the upper edge portion of the skirt is wrapped around the upper surface of the post 28 and secured in place with a suture 70. Wrapping the upper edge portion of the inner skirt 16 around the struts 28 in this manner provides a stronger and more durable attachment of the skirt to the frame. The inner skirt 16 may also be secured to the first, second and/or third rows of struts 22, 24 and 26, respectively, with sutures 70.
Referring again to fig. 12, in this embodiment, the skirt may experience greater elongation in the axial direction (i.e., the direction from the upper edge 82 to the lower edge 84) due to the angled orientation of the fibers relative to the upper and lower edges.
Thus, when the metal frame 12 is crimped (as shown in fig. 13), the inner skirt 16 may be elongated in the axial direction with the frame and thus provide a more uniform and predictable crimping profile. Each mesh of the metal frame in the illustrated embodiment includes at least four angled struts that rotate toward the axial direction when crimped (e.g., the angled struts become more aligned with the length of the frame). The angled struts of each mesh act as a mechanism to rotate the fibers of the skirt in the same direction of the struts, allowing the skirt to elongate along the length of the struts. This allows for greater elongation of the skirt and avoids undesirable deformation of the struts as the prosthetic valve is crimped.
Furthermore, the spacing between the braided fibers or yarns may be increased to facilitate elongation of the skirt in the axial direction. For example, for a PET inner skirt 16 formed from 20 denier yarns, the yarn density may be about 15% to about 30% less than a conventional PET skirt. In some examples, the inner skirt 16 may have a yarn spacing of from about 60 yarns per centimeter (about 155 yarns per inch) to about 70 yarns per centimeter (about 180 yarns per inch), such as about 63 yarns per centimeter (about 160 yarns per inch), while in conventional PET skirts the yarn spacing may be from about 85 yarns per centimeter (about 217 yarns per inch) to about 97 yarns per centimeter (about 247 yarns per inch). The beveled edges 86, 88 promote a uniform and consistent distribution of the fabric material along the inner circumference of the frame during crimping so that uniform crimping is the smallest possible diameter. In addition, cutting the diagonal seam in a perpendicular fashion may leave loose fringes along the cut edge. The beveled edges 86, 88 help minimize this from happening.
In alternative embodiments, the skirt may be formed from braided elastic fibers that may stretch in the axial direction during crimping of the prosthetic valve. The warp and weft fibers may extend perpendicular to and parallel to the upper and lower edges of the skirt, or alternatively, as described above, they may extend at an angle of between 0 and 90 degrees relative to the upper and lower edges of the skirt.
The inner skirt 16 may be sewn to the frame 12 at a location remote from the seam 154 so that the skirt may be more flexible in this region. This configuration may avoid stress concentrations on the sutures 154 attaching the lower edge of the leaflet to the inner skirt 16.
As described above, the leaflet structure 14 in the illustrated embodiment includes three flexible leaflets 41 (although a greater or lesser number of leaflets may be used). Additional information about the leaflets and about the skirt material can be found, for example, in U.S. patent application No. 14/704861 filed on 5/2015.
The leaflets 41 can be secured to each other on their adjacent sides to form commissures 122 of the leaflet structure. A plurality of flexible connectors 124 (one of which is shown in fig. 17) may be used to interconnect adjacent sides of the paired leaflets and connect the leaflets to the commissure window frame portions 30 (fig. 5).
Figure 17 shows adjacent sides of two leaflets 41 interconnected by a flexible connector 124. As shown in fig. 18, three flexible connectors 124 may be used to secure three leaflets 41 to each other side-by-side. Additional information about the connection of the leaflets to each other and to the frame can be found, for example, in U.S. patent application publication No. 2012/0123599.
As described above, the inner skirt 16 may be used to assist in suturing the leaflet structure 14 to the frame. The inner skirt 16 may have undulating temporary marker sutures to guide the attachment of the lower edge of each leaflet 41. As described above, the inner skirt 16 itself may be sewn to the struts of the frame 12 using the sutures 70 prior to securing the leaflet structure 14 to the skirt 16. The struts intersecting the marker sutures are desirably unattached to the inner skirt 16. This allows the inner skirt 16 to be more flexible in the areas not secured to the frame and minimizes stress concentrations along the sutures that secure the lower edges of the leaflets to the skirt. As described above, when the skirt is secured to the frame, the fibers 78, 80 (see FIG. 12) of the skirt are generally aligned with the angled struts of the frame to promote uniform crimping and expansion of the frame.
Fig. 19 illustrates one particular method for securing the commissures 122 of the leaflet structure 14 to the commissure window frame portion 30 of the frame. In this approach, the flexible connector 124 (fig. 18) securing two adjacent sides of two leaflets is folded laterally and the upper tab portion 112 is folded down against the flexible connector. Each upper tab portion 112 is folded longitudinally (vertically) to assume an L-shape, with the first portion 142 folded against the surface of the leaflet and the second portion 144 folded against the connector 124. The second portion 144 may then be stitched to the connector 124 along the stitching 146. Next, the commissure tab assemblies are inserted through the commissure windows 20 of the respective window frame portions 30, and the folds outside of the window frame portions 30 can be stitched to the second portions 144.
Figure 19 also shows that the folded down upper tab portion 112 can form a double layer of leaflet material at the commissures. The first portion 142 of the upper tab portion 112 is positioned flat against the layers of the two leaflets 41 forming the commissures such that each commissure includes only four layers of leaflet material inside the window frame 30. These four-ply portions of the commissures may be more resistant to bending or hinging than portions of the leaflets 41 radially inward of only the relatively stiffer four-ply portions. This allows the leaflets 41 to hinge primarily at the inner edge 143 of the folded down portion 142, rather than around or near the axial struts of the window frame 30, in response to blood flowing through the prosthetic valve during in vivo operation. Because the small She Jiaojie is spaced radially inward from the window frame 30, the leaflets can avoid touching and damaging the frame. However, under high forces, the four-layer portions of the commissures may unfold about a longitudinal axis adjacent to the window frame 30, each first portion 142 folding outwardly against a respective second portion 144. This may occur, for example, when the prosthetic valve 10 is crimped and mounted onto a delivery shaft, allowing for a smaller crimp diameter. When the balloon catheter is inflated during expansion of the prosthetic valve, the four layer portions of the commissures may also expand about the longitudinal axis, which may relieve some of the pressure on the commissures caused by the balloon, thereby reducing potential damage to the commissures during expansion.
After all three commissure tab assemblies are secured to the respective window frame portions 30, the lower edges of the leaflets 41 between the commissure tab assemblies can be sewn to the inner skirt 16. For example, as shown in FIG. 20, each leaflet 41 may use, for example, ethibondThe wire is sewn to the inner skirt 16 along a suture 154. The sutures may be through sutures extending through each leaflet 41, inner skirt 16, and each reinforcement band 72. Each leaflet 41 and corresponding reinforcing band 72 may be separately sewn to the inner skirt 16. In this manner, the lower edges of the leaflets are secured to the frame 12 by the inner skirt 16. As shown in fig. 20, the leaflets may be further secured to the skirt with a lock stitch 156, the lock stitch 156 extending through each of the reinforcement band 72, the leaflets 41 and the inner skirt 16, while encircling the edges of the reinforcement band 72 and the leaflets 41. The lockstitch suture 156 may be formed from a PTFE suture material. Figure 21 shows a side view of the frame 12, the leaflet structure 14, and the inner skirt 16 after securing the leaflet structure 14 and the inner skirt 16 to the frame 12 and securing the leaflet structure 14 to the inner skirt 16.
Fig. 22-23 illustrate another embodiment of an outer skirt or sealing member 200 that may be incorporated into a prosthetic valve, such as valve 10. Fig. 22 shows a plan view of the outer skirt 200 prior to its attachment to the prosthetic heart valve. Fig. 23 shows a view of the outer skirt 200 in a cylindrical configuration prior to its attachment to a prosthetic heart valve.
Referring to fig. 22-23, the outer skirt 200 may include an upper edge portion 202, a lower edge portion 204, and an intermediate portion 206 disposed between the upper edge portion 202 and the lower edge portion 204. The intermediate portion 206 may include a plurality of vertical slits, cuts, or openings 208 cut or otherwise formed at circumferentially spaced locations in the outer skirt 200. Each pair of adjacent slits 208 define a vertical strip 210 (also referred to as a skirt section) therebetween such that there are a plurality of such strips 210, each strip 210 extending longitudinally along the length of the outer skirt 200 from the upper edge portion 202 to the lower edge portion 204. Each strap 210 in the illustrated embodiment defines opposing longitudinally extending edge portions 212 adjacent to the respective slit 208.
The outer skirt 200 may be formed of the following materials: synthetic materials, including woven, nonwoven, or nonwoven materials (e.g., foams, sheets) formed from any of a variety of suitable biocompatible polymers, such as PET, PTFE, ePTFE, polyurethane, polyester; natural tissue (pericardium); and/or other suitable materials configured to restrict and/or prevent blood flow therethrough. Alternatively, the outer skirt 200 may be formed of an elastic material. Slit 208 may be formed by laser cutting or any other suitable means. As described below in connection with fig. 24-25, the outer skirt 200 may be secured to the frame of a prosthetic heart valve.
The slit 208 in the illustrated embodiment is straight, thus defining a rectangular strip 210. However, in other embodiments, the slit 208 may have various other shapes, including curved portions, so as to define various shaped strips 210. For example, the slit 208 may have a wavy shape or a sinusoidal shape so as to define a strip 210 having longitudinal sides of the same shape. Further, as shown in the illustrated embodiment, the slit 208 terminates near the upper and lower edges of the skirt. In this way, the strips 210 are connected to each other at their upper and lower ends by the upper and lower edge portions 202, 204 of the skirt. In other embodiments, one or more slits 208 may extend all the way to the upper or lower edge of the skirt such that strips 210 are not connected to adjacent strips, with slits 208 extending all the way to the upper or lower edge of the skirt.
Fig. 24-25 illustrate the outer skirt 200 of fig. 22-23 mounted on the outside of the frame 12. Fig. 25 shows an enlarged view of a portion of the frame 12 and the outer skirt 200. The frame 12 and outer skirt 200 may be part of a prosthetic heart valve similar to the prosthetic heart valve 10, which may include a valve structure similar to the valve structure 14 and an inner skirt similar to the inner skirt 16, as best shown in fig. 1-3. For purposes of illustration, fig. 24-25 only show the frame 12 and the outer skirt 200.
As previously described and as best shown in fig. 5, the frame 12 includes struts 34 extending axially between the angled struts 22, 24 of rows I and II. The first row of struts I, the second row of struts II, and the axially extending struts 34 define a plurality of cells defining openings 36. Prior to attachment to the frame 12, the outer skirt 200 may be disposed about the outer surface of the frame 12 such that each slit 208 is adjacent to an axially extending strut 34 and such that each band 210 substantially covers one of the cell openings 36. The upper edge portion 202 and lower edge portion 204 of the outer skirt 200 may be secured to the frame 212 using suitable techniques and/or mechanisms, including sutures, adhesives, and/or ultrasonic welding. In particular embodiments, for example, the entire extent of lower edge portion 204 may be stitched to the I-row angled struts 22 of frame 12, while upper edge portion 202 may be stitched at the junction formed by the intersection of struts 26 and struts 28. In other embodiments, the entire extent of upper edge portion 202 may be stitched to either strut 26 or strut 28. In some embodiments, the upper edge portion 202 may have a wavy or scalloped shape, such as shown by skirt 18, and may be stitched to the frame 12, as shown in fig. 1.
In particular embodiments, the height H of the outer skirt 200 in the axial direction may be greater than the axial distance between the attachment locations of the upper and lower edge portions 202, 204 of the outer skirt 200 when the frame 12 is in the radially contracted configuration. In this manner, radial expansion of the frame 12 results in shortening of the frame 12 between the attachment locations of the skirt 200, creating slack in the skirt 200 between the attachment locations and allowing the straps 210 to move outwardly from the frame 12. In the example shown, the axial length of the outer skirt 200 is equal to the length of the struts 22 plus the length of the struts 34 plus the length of the struts 24 plus the length of the struts 26 of the frame 12. In alternative embodiments, the outer skirt 200 may have a different height H, depending on the particular application.
In addition to the upper and lower ends 202, 204 being secured to the frame 12, at least one of the longitudinal edge portions 212 of each of the plurality of straps 210 may be secured to the frame 12 and/or other straps to create circumferential and/or twisting movement of the straps 210 as the frame 12 radially expands. In the example shown, the strap 210 is secured to the frame 12 by a tether 214, which tether 214 may be, for example, a suture, flexible wire, filament, or similar material. Alternatively, the straps 210 may be secured to the frame 12 by adhesive and/or ultrasonic welding in addition to or in lieu of the suture.
In the illustrated embodiment, for each of the plurality of straps 210, the edge portion 212a may be secured to the post 34 by a tether 214, the tether 214 having one end 214a tied or knotted around the post 34 and the other end 214b tied to the strap 212. Desirably, the edge 212a of the strap 210 is secured to the brace 34 nearest the unsecured edge 212b of the same strap such that the tether 214 extends across the width of the strap 210 and unsecured edge 212 b. Thus, when the frame 12 is in the radially contracted configuration, the axially extending struts 34 are closer together, and the band 210 extends in a generally straight line between the upper and lower edges 202, 204 of the skirt 200. However, as the frame 12 expands to the radially expanded configuration, the axially extending struts 34 move away from each other, pulling the fixed edge 212a of each strap 210 toward its unsecured edge 212b, thereby reducing the width of the strap 210 between its upper and lower ends (the width of the strap extending in the circumferential direction) and creating a longitudinal fold in the strap 210. In this manner, the strips 210 form rib-like projections that may also extend radially outward from the frame 12 due to the shortening of the frame 12 as it radially expands.
In the illustrated embodiment, the tether 214 is positioned radially outward of the skirt 200. In some embodiments, the tether 214 may be positioned radially inside the skirt 200. In other embodiments, some of the tethers 214 may be positioned outside of the skirt 200 while other tethers 214 are positioned inside of the skirt 200. When a prosthetic valve (e.g., valve 10 with outer skirt 200) is implanted in a native annulus, the protrusions formed by the strips 210 can contact surrounding tissue and form a seal to prevent or minimize paravalvular leakage.
Fig. 26-27 illustrate another embodiment including a frame 12 and an outer skirt 200. The embodiment of fig. 26-27 is identical to the embodiment of fig. 24-25, except for the manner in which the skirt 200 is secured to the frame 12. As described above with respect to the embodiments of fig. 24-25, the embodiments of fig. 26-27 may include a valve structure, such as valve structure 14, and an inner skirt, such as inner skirt 16 (as best shown in fig. 1-3), to form a prosthetic heart valve. For purposes of illustration, fig. 26-27 only show the frame 12 and the outer skirt 200.
26-27, As previously described, the upper edge portion 202 and the lower edge portion 204 of the outer skirt 200 may be secured to the frame 12. The first longitudinal edge portion 212a of each strap 210 may be secured to the strut 34a adjacent to the second longitudinal edge portion 212b of the same strap 210 by a first tether 214. The first tether 214 extends across the width of the strap 210 and has a first end 214a that is tied or knotted around the strut 34a and a second end 214b that is secured to the edge portion 212 a. The second longitudinal edge portion 212b is secured to the post 34b adjacent the first edge portion 212a by a second tether 216. Second tether 216 extends across the width of the strap and has a first end 216a that is tied or knotted around post 34b and a second end 216b that is secured to second edge portion 212 b.
The tethers 214, 216 are desirably located on opposite sides of the skirt 200. As shown in the illustrated embodiment, the first tether 214 is positioned radially outside of the skirt 200, while the second tether 216 is positioned radially inside of the skirt 200. Thus, when the frame 12 expands to the radially expanded configuration (such that the struts 34a, 34b move away from one another), the first edge portion 212a is pulled toward the second edge portion 212b by the first tether 214 and the second edge portion 212b is pulled toward the first edge portion 212a. Pulling of the tethers 214, 216 reduces the width of the band 210 and creates a longitudinal fold, and also causes the band 210 to twist or rotate slightly as the tethers 214, 216 are located on opposite sides of the outer skirt 200. As previously mentioned, the bands 210 may also protrude radially from the frame 12 as the frame shortens, forming ribbed protrusions that may help seal the prosthetic valve to the native annulus. In alternative embodiments, the tethers 214, 216 may be on the same side of the skirt 200 (i.e., both tethers 214, 216 may be positioned radially outside of the skirt 200 or inside of the skirt 200), in which case the band 210 assumes a similar shape when the frame expands, but without twisting the opposing edge portions 212a, 212 b.
Fig. 28-29 illustrate another embodiment including a frame 12 and an outer skirt 200. The embodiment of fig. 28-29 is identical to the embodiment of fig. 24-25, except for the manner in which the skirt 200 is secured to the frame 12. As described above with respect to the embodiments of fig. 24-25, the embodiments of fig. 28-29 may include a valve structure, such as valve structure 14, and an inner skirt, such as inner skirt 16 (as best shown in fig. 1-3), to form a prosthetic heart valve. For purposes of illustration, fig. 28-29 only show the frame 12 and the outer skirt 200. In this embodiment, the skirt segments are coupled to one another by tethers (rather than struts of the frame) to create movement of the skirt segments as the frame radially expands.
28-29, As previously described, the upper edge portion 202 and the lower edge portion 204 of the outer skirt 200 may be secured to the frame 12. The outer skirt 200 includes a plurality of strips 210a and 210b alternately positioned about the outer surface of the frame 12, which are similar to the strips 210 of fig. 24-25 except how they are secured to the frame 12. The first longitudinal edge portion 212a of each strap 210a may be secured to the longitudinal edge portion 212c of an adjacent strap 210b by a first tether 218. First tether 218 may extend across the width of straps 210a and 210b and may have a first end 218a secured to edge portion 212c and a second end 218b secured to edge portion 212 a. The second longitudinal edge portion 212b of each strap 210a may be secured to the longitudinal edge portion 212d of an adjacent strap 210b on the other side of the strap 210a by a second tether 220. The second tether 220 may extend across the width of the straps 210a and 210b and may have a first end 220a secured to the edge portion 212b and a second end 220b secured to the edge portion 212d. In this manner, each strap 210a is coupled to two straps 210b located on opposite sides of strap 210a by tethers 218, 220. Each strap 210b may be coupled to two straps 210a in the same manner.
Tethers 218, 220 are desirably located on opposite sides of skirt 200. As shown in the illustrated embodiment, first tether 218 is positioned radially inside skirt 200, while second tether 216 is positioned radially outside skirt 200. Thus, when the frame 12 expands to the radially expanded configuration, the edge portions 212a, 212c of the straps 210a, 210b, respectively, are drawn inwardly toward each other, while the edge portions 212b, 212d of the straps 210a, 210b, respectively, are drawn outwardly toward each other. Pulling of the straps 210a, 210b causes the width of the straps 210a, 210b to decrease and form a longitudinal fold, and also causes the straps 210a, 210b to twist or rotate slightly as a result of the tethers 218, 220 being located on opposite sides of the outer skirt 200. As previously mentioned, the bands 210a, 210b may also protrude radially from the frame 12 as the frame shortens, forming ribbed protrusions that may help seal the prosthetic valve to the native annulus. In alternative embodiments, tethers 218, 220 may be on the same side of skirt 200 (i.e., both tethers 218, 220 may be positioned radially outside of skirt 200 or inside of skirt 200), in which case straps 210a, 210b take on a similar shape when the frame expands, but without twisting the opposing edge portions 212a, 212b, 212c, 212 d.
In the embodiment of fig. 28-29, each edge portion of a strip is coupled to the furthest edge portion of an adjacent strip. In alternative embodiments, each edge portion of a strip may be coupled to a closer edge portion of an adjacent strip. For example, edge portion 212a of strap 210a may be coupled to edge portion 212d of one strap 210b by tether 218, while edge portion 212b may be coupled to edge portion 212c by tether 220 of another strap 210 b. In other embodiments, the different techniques described above for coupling the skirt strips to the frame struts and to each other may be combined in a single prosthetic valve. For example, the skirt 200 may have some straps coupled to the frame struts in the manner shown in fig. 24-25, some straps coupled to the frame struts in the manner shown in fig. 26-27, and some straps coupled to each other in the manner shown in fig. 28-29 and/or described above.
In alternative embodiments, instead of having a single skirt mounted on the outside of the frame, the outer sealing member may comprise a plurality of discrete sealing segments positioned side by side around the circumference of the frame. For example, instead of cutting the slit 208 in the skirt 200, the skirt 200 may be cut along a cutting line extending from the lower edge to the upper edge at the position of the slit 208 in fig. 22 to form a plurality of rectangular seal segments. Each discrete seal segment may be secured to the frame at upper and lower edge portions thereof. Each discrete seal segment may be coupled to the frame and/or one or more other seal segments by using one or more tethers of any of the configurations described above.
The prosthetic valve 10 can be configured and mounted on a suitable delivery device for implantation in a patient. Several catheter-based delivery devices may be used; non-limiting examples of suitable catheter-based delivery devices include those disclosed in U.S. patent application publication No.2013/0030519 and U.S. patent application publication No. 2012/0123599.
In one example, to implant the plastically-expandable prosthetic valve 10 in a patient, the prosthetic valve 10 including the frame 12 and the outer skirt 200 may be crimped onto the elongate shaft 180 of the delivery device, as best shown in fig. 13. The prosthetic valve may form a delivery assembly with a delivery device for implanting the prosthetic valve 10 into a patient. The shaft 180 includes an inflatable balloon 182 for expanding the prosthetic valve in vivo. Following deflation of the balloon 182, the prosthetic valve 10 can then be delivered percutaneously to a desired implantation site (e.g., a native aortic valve region). Once the prosthetic valve 10 is delivered to an implantation site in the body (e.g., a native aortic valve), the prosthetic valve 10 can be radially expanded to its functional state by inflating the balloon 182.
Alternatively, the self-expanding prosthetic valve 10 may be crimped into a radially contracted configuration and restrained in the contracted configuration by inserting the prosthetic valve 10 comprising the frame 12 and outer skirt 200 into a sheath or equivalent mechanism of a delivery catheter. The prosthetic valve 10 can then be delivered percutaneously to the desired implantation site. Once inside the body, the prosthetic valve 10 can be advanced from the delivery sheath, which allows the prosthetic valve 10 to expand to its functional state.
Fig. 30-32 and 35 illustrate various implantation locations of the prosthetic heart valve 10 (with an outer skirt 200 instead of the outer skirt 18 described above in connection with fig. 24-29), including implantation into a docking portion or anchor placed within a patient prior to valve implantation. In the embodiment shown in fig. 30-31, the outer skirt 200 is configured in the manner described in connection with fig. 24-25. In other embodiments, the outer skirt 200 of FIGS. 30-31 may be configured in the manner described in connection with FIGS. 26-27 or in the manner described in connection with FIGS. 28-29. Fig. 30 shows a prosthetic heart valve 10 implanted in a native aortic valve of a patient.
Fig. 31 shows a prosthetic heart valve 10 implanted in a patient's pulmonary artery for replacing or enhancing the function of a diseased pulmonary valve. The prosthetic valve 10 may be implanted in a radially expandable external docking device 300 due to variations in the size and shape of the native pulmonary valve and pulmonary artery. The interface 300 may include a radially expandable and compressible annular stent 302 and a sealing member 304, the sealing member 304 covering all or a portion of the stent and may extend across an inner and/or outer surface of the stent. The docking device 300 is configured to engage the inner wall of the pulmonary artery and can accommodate changes in patient anatomy. The docking device 300 may also compensate for the expanded prosthetic heart valve 310 being much smaller than the vessel in which it is placed. The docking device 300 may also be used to support a prosthetic valve in other areas of the patient's anatomy, such as the inferior vena cava, superior vena cava, or aorta. Further details of the docking device 300 and methods for implanting the docking device and prosthetic valve are disclosed in co-pending U.S. application No.15/422354, filed on, for example, month 2 and 1 of 2017.
Fig. 32 shows a prosthetic heart valve 10 implanted in a patient's native mitral valve using a docking device in the form of a helical anchor 400. The helical anchor 400 may include one or more coils 402 disposed in the left atrium and one or more coils 404 disposed in the left ventricle and radially outward of the native mitral valve leaflet 406. When the prosthetic valve 10 is deployed within the native valve, the native valve is compressed or sandwiched between the prosthetic valve 410 and the anchor 400 to hold the prosthetic valve in place. Further details of the helical anchor 400 and the method for implanting the anchor and prosthetic valve are disclosed in co-pending U.S. application No.62/395940, filed on, for example, date 2016, 9, 16.
Fig. 33 and 34 illustrate a docking device 500 for a prosthetic heart valve according to another embodiment. Docking device 500 may include a radially expandable and compressible frame 502, with frame 502 having an outer portion 504, an inner portion 506 coaxially disposed within an end of outer portion 504, and a curved transition portion 508 extending between and connecting inner portion 506 and outer portion 504. The interface 500 may also include a sealing member 510 extending over an inner surface of the inner portion 506, a portion of an outer surface of the outer portion 504 adjacent the inner portion 506, and a transition portion 508.
Fig. 35 shows the docking device 500 implanted in a blood vessel 520, which vessel 520 may be, for example, the inferior vena cava, superior vena cava, or ascending aorta. As shown, the prosthetic valve 10 can be disposed within the interior portion 1606 of the docking device 500. Similar to the docking device 300, the docking device 500 may compensate for the expanded prosthetic heart valve 10 being much smaller than the vessel in which it is placed. The docking device 500 is particularly suited for implantation of a prosthetic valve in the inferior vena cava to replace or augment the function of the native tricuspid valve. Further details of the docking device 500 and methods for implanting the docking device and prosthetic valve are disclosed in co-pending U.S. application No.16/034794, filed on, for example, day 13, 7, 2018.
General considerations
It should be appreciated that the disclosed valve may be implanted in any native annulus of the heart (e.g., the pulmonary valve annulus, the mitral valve annulus, and the tricuspid valve annulus), and may be used with any of a variety of methods (e.g., retrograde, antegrade, transseptal, transventricular, transatrial, etc.). The disclosed prosthesis may also be implanted in other lumens of the body.
For purposes of description, certain aspects, advantages, and novel features of the disclosed embodiments are described herein. The disclosed methods, apparatus, and systems should not be construed as limiting in any way. Rather, the present disclosure is directed to all novel and nonobvious features and aspects of the various disclosed embodiments, both separately and in various combinations and subcombinations with one another. The methods, apparatus and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed embodiments are described in a particular order for ease of presentation, it should be understood that this manner of description includes rearrangement, unless a particular order is required by the particular language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods.
As used in this specification and the claims, the singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. Furthermore, the term "comprising" means "including.
As used herein, the term "and/or" as used between the last two of a list of elements means any one or more of the listed elements. For example, the phrase "A, B and/or C" means "a", "B", "C", "a and B", "a and C", "B and C" or "A, B and C".
As used herein, the term "proximal" refers to the location, direction, or portion of the device that is closer to the user and further from the implantation site. As used herein, the term "distal" refers to the location, direction, or portion of the device that is distal to the user and closer to the implantation site. Thus, for example, proximal movement of the device is movement of the device toward the user, while distal movement of the device is movement of the device away from the user. The terms "longitudinal" and "axial" refer to axes extending in proximal and distal directions unless explicitly defined otherwise.
As used herein, the terms "coupled" and "associated" generally mean physically coupled or linked, and do not exclude the presence of intermediate elements between coupled or associated items in the absence of a particular reverse language.
As used herein, operations that occur "concurrently" or "concurrently" generally occur concurrently with each other, although delays in one operation relative to another operation due to, for example, spacing, play or clearance between components in a mechanical connection (such as threads, gears, etc.) are well within the scope of the above terms and are not specifically to the contrary.
In view of the many possible embodiments to which the principles disclosed herein may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the present disclosure. Rather, the scope of the present disclosure is at least as broad as the following claims.

Claims (11)

1. An implantable prosthetic valve, comprising:
An annular frame including an inflow end and an outflow end and being radially contractible and expandable between a radially contracted configuration and a radially expanded configuration, the frame defining an axial direction extending from the inflow end to the outflow end;
a leaflet structure positioned within and secured to the frame; and
An outer sealing member positioned about an outer surface of the frame, wherein the outer sealing member comprises a plurality of sealing segments, wherein each sealing segment extends longitudinally in the axial direction between an upper edge portion and a lower edge portion of the outer sealing member; and
Wherein each seal segment is coupled to the frame and/or another seal segment by at least a first tether that pulls a portion of the seal segment in a circumferential direction when the frame is radially expanded to the radially expanded configuration such that the seal segment decreases in width between its upper and lower ends in the circumferential direction and forms a longitudinal fold in the seal segment.
2. The implantable prosthetic valve of claim 1, wherein the portion of the sealing segment is one of a first longitudinal edge portion and a second longitudinal edge portion of the sealing segment.
3. The implantable prosthetic valve of claim 1, wherein the first tether is coupled to a first longitudinal edge portion of the sealing segment.
4. The implantable prosthetic valve of claim 3, wherein each sealing segment is coupled to the frame and/or another sealing segment by a second tether that pulls a second longitudinal edge portion of the sealing segment in the circumferential direction when the frame is radially expanded to the expanded configuration.
5. The implantable prosthetic valve of claim 4, wherein the first tether and the second tether are disposed on opposite sides of the outer sealing member.
6. The implantable prosthetic valve of claim 4, wherein the first tether and the second tether are disposed on opposite sides of the outer sealing member in a radial direction.
7. The implantable prosthetic valve of claim 1, wherein each seal segment has an upper portion and a lower portion connected to the frame at axially spaced locations on the frame, the upper and lower portions moving toward each other upon radial expansion of the frame and causing a portion of the seal segments to move radially outward away from the frame.
8. The implantable prosthetic valve of claim 1, wherein a width of each sealing segment in a circumferential direction is reduced upon radial expansion of the frame by a pulling force of a tether connected to the sealing segment.
9. The implantable prosthetic valve of claim 7, wherein a width of each sealing segment in a circumferential direction is reduced by a pulling force of a tether connected to the sealing segment as the frame radially expands.
10. The implantable prosthetic valve of claim 1, wherein each sealing segment becomes at least partially distorted upon radial expansion of the frame by a pulling force of a tether connected to the sealing segment.
11. The implantable prosthetic valve of claim 1, wherein each tether has one end secured to a sealing segment and another end secured to the frame or another sealing segment.
CN202111060324.0A 2017-08-21 2018-08-20 Sealing member for prosthetic heart valve Active CN113730033B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111060324.0A CN113730033B (en) 2017-08-21 2018-08-20 Sealing member for prosthetic heart valve

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762548280P 2017-08-21 2017-08-21
US62/548,280 2017-08-21
US16/103,985 US10722353B2 (en) 2017-08-21 2018-08-16 Sealing member for prosthetic heart valve
US16/103,985 2018-08-16
CN202111060324.0A CN113730033B (en) 2017-08-21 2018-08-20 Sealing member for prosthetic heart valve
PCT/US2018/047071 WO2019040364A1 (en) 2017-08-21 2018-08-20 Sealing member for prosthetic heart valve
CN201880063963.2A CN111163730B (en) 2017-08-21 2018-08-20 Sealing member for artificial heart valve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880063963.2A Division CN111163730B (en) 2017-08-21 2018-08-20 Sealing member for artificial heart valve

Publications (2)

Publication Number Publication Date
CN113730033A CN113730033A (en) 2021-12-03
CN113730033B true CN113730033B (en) 2024-06-07

Family

ID=65360270

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201880063963.2A Active CN111163730B (en) 2017-08-21 2018-08-20 Sealing member for artificial heart valve
CN202111060324.0A Active CN113730033B (en) 2017-08-21 2018-08-20 Sealing member for prosthetic heart valve

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201880063963.2A Active CN111163730B (en) 2017-08-21 2018-08-20 Sealing member for artificial heart valve

Country Status (8)

Country Link
US (3) US10722353B2 (en)
EP (3) EP4591829A3 (en)
KR (1) KR102619515B1 (en)
CN (2) CN111163730B (en)
CA (1) CA3072239A1 (en)
DK (1) DK3672528T3 (en)
ES (1) ES2900642T3 (en)
WO (1) WO2019040364A1 (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10561509B2 (en) 2013-03-13 2020-02-18 DePuy Synthes Products, Inc. Braided stent with expansion ring and method of delivery
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
EP3107495B2 (en) 2014-02-18 2025-05-14 St. Jude Medical, Cardiology Division, Inc. Bowed runners and corresponding valve assemblies for paravalvular leak protection
US10206796B2 (en) 2014-08-27 2019-02-19 DePuy Synthes Products, Inc. Multi-strand implant with enhanced radiopacity
US11045312B2 (en) * 2015-02-02 2021-06-29 Boston Scientific Limited Stent seals and method of production
EP3389557B1 (en) 2015-12-15 2022-07-13 Neovasc Tiara Inc. Transseptal delivery system
US11833034B2 (en) 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US10433952B2 (en) 2016-01-29 2019-10-08 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
US10179043B2 (en) * 2016-02-12 2019-01-15 Edwards Lifesciences Corporation Prosthetic heart valve having multi-level sealing member
US10076428B2 (en) 2016-08-25 2018-09-18 DePuy Synthes Products, Inc. Expansion ring for a braided stent
US10292851B2 (en) 2016-09-30 2019-05-21 DePuy Synthes Products, Inc. Self-expanding device delivery apparatus with dual function bump
US10182927B2 (en) * 2016-10-21 2019-01-22 DePuy Synthes Products, Inc. Expansion ring for a braided stent
CN113893064A (en) 2016-11-21 2022-01-07 内奥瓦斯克迪亚拉公司 Methods and systems for rapid retrieval of transcatheter heart valve delivery systems
US11185406B2 (en) * 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
US10856971B2 (en) * 2017-08-18 2020-12-08 Edwards Lifesciences Corporation Sealing members for prosthetic heart valve
CA3073834A1 (en) 2017-08-25 2019-02-28 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US11147667B2 (en) * 2017-09-08 2021-10-19 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
WO2019195860A2 (en) 2018-04-04 2019-10-10 Vdyne, Llc Devices and methods for anchoring transcatheter heart valve
AU2019204522A1 (en) 2018-07-30 2020-02-13 DePuy Synthes Products, Inc. Systems and methods of manufacturing and using an expansion ring
US10278848B1 (en) 2018-08-06 2019-05-07 DePuy Synthes Products, Inc. Stent delivery with expansion assisting delivery wire
US10456280B1 (en) 2018-08-06 2019-10-29 DePuy Synthes Products, Inc. Systems and methods of using a braided implant
CA3279869A1 (en) 2018-08-21 2025-11-29 Shifamed Holdings Llc Prosthetic cardiac valve devices, systems, and methods
US12186187B2 (en) 2018-09-20 2025-01-07 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US10321995B1 (en) 2018-09-20 2019-06-18 Vdyne, Llc Orthogonally delivered transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
CA3115270A1 (en) 2018-10-05 2020-04-09 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
WO2020082039A1 (en) 2018-10-19 2020-04-23 Shifamed Holdings, Llc Adjustable medical device
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11737872B2 (en) 2018-11-08 2023-08-29 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US10653522B1 (en) 2018-12-20 2020-05-19 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valve prosthesis
US11039944B2 (en) 2018-12-27 2021-06-22 DePuy Synthes Products, Inc. Braided stent system with one or more expansion rings
WO2020146842A1 (en) 2019-01-10 2020-07-16 Vdyne, Llc Anchor hook for side-delivery transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
AU2020231221B2 (en) 2019-03-05 2025-07-31 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
WO2020185597A1 (en) 2019-03-08 2020-09-17 Neovasc Tiara Inc. Retrievable prosthesis delivery system
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US10631983B1 (en) 2019-03-14 2020-04-28 Vdyne, Inc. Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis
US10758346B1 (en) 2019-03-14 2020-09-01 Vdyne, Inc. A2 clip for side-delivered transcatheter mitral valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
EP3941391B1 (en) 2019-03-19 2024-12-04 Shifamed Holdings, LLC Prosthetic cardiac valve devices, systems
CN113811265B (en) 2019-04-01 2024-11-29 内奥瓦斯克迪亚拉公司 Prosthetic valve capable of being deployed in a controlled manner
CN113924065B (en) 2019-04-10 2026-01-30 内奥瓦斯克迪亚拉公司 Prosthetic valve with natural blood flow
CA3138875A1 (en) 2019-05-04 2020-11-12 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
WO2020236931A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
EP3986332A4 (en) 2019-06-20 2023-07-19 Neovasc Tiara Inc. Low profile prosthetic mitral valve
AU2020334080B2 (en) 2019-08-20 2025-11-27 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
CN120531525A (en) 2019-08-26 2025-08-26 维迪内股份有限公司 Laterally deliverable transcatheter prosthetic valve and method for its delivery and anchoring
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
US12053371B2 (en) 2020-08-31 2024-08-06 Shifamed Holdings, Llc Prosthetic valve delivery system
US12329635B2 (en) 2020-12-04 2025-06-17 Shifamed Holdings, Llc Flared prosthetic cardiac valve delivery devices and systems
US12201521B2 (en) 2021-03-22 2025-01-21 Shifamed Holdings, Llc Anchor position verification for prosthetic cardiac valve devices
WO2026006535A1 (en) * 2024-06-27 2026-01-02 Edwards Lifesciences Corporation Prosthetic heart valve

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022124A1 (en) * 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
CN105324091A (en) * 2014-05-12 2016-02-10 爱德华兹生命科学公司 prosthetic heart valve

Family Cites Families (312)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE144167C (en) 1903-09-28
GB1127325A (en) 1965-08-23 1968-09-18 Henry Berry Improved instrument for inserting artificial heart valves
US3587115A (en) 1966-05-04 1971-06-28 Donald P Shiley Prosthetic sutureless heart valves and implant tools therefor
US3548417A (en) 1967-09-05 1970-12-22 Ronnie G Kischer Heart valve having a flexible wall which rotates between open and closed positions
USRE30912E (en) 1968-09-16 1982-04-27 Hancock Laboratories, Inc. Stent for heart valve
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US3755823A (en) 1971-04-23 1973-09-04 Hancock Laboratories Inc Flexible stent for heart valve
GB1402255A (en) 1971-09-24 1975-08-06 Smiths Industries Ltd Medical or surgical devices of the kind having an inflatable balloon
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
CA1069652A (en) 1976-01-09 1980-01-15 Alain F. Carpentier Supported bioprosthetic heart valve with compliant orifice ring
US4056854A (en) 1976-09-28 1977-11-08 The United States Of America As Represented By The Department Of Health, Education And Welfare Aortic heart valve catheter
US4297749A (en) 1977-04-25 1981-11-03 Albany International Corp. Heart valve prosthesis
US4265694A (en) 1978-12-14 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making unitized three leaflet heart valve
US4222126A (en) 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US4574803A (en) 1979-01-19 1986-03-11 Karl Storz Tissue cutter
GB2056023B (en) 1979-08-06 1983-08-10 Ross D N Bodnar E Stent for a cardiac valve
US4373216A (en) 1980-10-27 1983-02-15 Hemex, Inc. Heart valves having edge-guided occluders
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
US4339831A (en) 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US4470157A (en) 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4345340A (en) 1981-05-07 1982-08-24 Vascor, Inc. Stent for mitral/tricuspid heart valve
US4406022A (en) 1981-11-16 1983-09-27 Kathryn Roy Prosthetic valve means for cardiovascular surgery
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
IT1212547B (en) 1982-08-09 1989-11-30 Iorio Domenico INSTRUMENT FOR SURGICAL USE INTENDED TO MAKE INTERVENTIONS FOR THE IMPLANTATION OF BIOPROTESIS IN HUMAN ORGANS EASIER AND SAFER
GB8300636D0 (en) 1983-01-11 1983-02-09 Black M M Heart valve replacements
US4535483A (en) 1983-01-17 1985-08-20 Hemex, Inc. Suture rings for heart valves
US4612011A (en) 1983-07-22 1986-09-16 Hans Kautzky Central occluder semi-biological heart valve
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4627436A (en) 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4592340A (en) 1984-05-02 1986-06-03 Boyles Paul W Artificial catheter means
US5007896A (en) 1988-12-19 1991-04-16 Surgical Systems & Instruments, Inc. Rotary-catheter for atherectomy
US4979939A (en) 1984-05-14 1990-12-25 Surgical Systems & Instruments, Inc. Atherectomy system with a guide wire
US4883458A (en) 1987-02-24 1989-11-28 Surgical Systems & Instruments, Inc. Atherectomy system and method of using the same
DE3426300A1 (en) 1984-07-17 1986-01-30 Doguhan Dr.med. 6000 Frankfurt Baykut TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS
DE3442088A1 (en) 1984-11-17 1986-05-28 Beiersdorf Ag, 2000 Hamburg HEART VALVE PROSTHESIS
SU1271508A1 (en) 1984-11-29 1986-11-23 Горьковский государственный медицинский институт им.С.М.Кирова Artificial heart valve
US4759758A (en) 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
FR2587614B1 (en) 1985-09-23 1988-01-15 Biomasys Sa PROSTHETIC HEART VALVE
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
CH672247A5 (en) 1986-03-06 1989-11-15 Mo Vysshee Tekhnicheskoe Uchil
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4777951A (en) 1986-09-19 1988-10-18 Mansfield Scientific, Inc. Procedure and catheter instrument for treating patients for aortic stenosis
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4878495A (en) 1987-05-15 1989-11-07 Joseph Grayzel Valvuloplasty device with satellite expansion means
US4796629A (en) 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4829990A (en) 1987-06-25 1989-05-16 Thueroff Joachim Implantable hydraulic penile erector
US4851001A (en) 1987-09-17 1989-07-25 Taheri Syde A Prosthetic valve for a blood vein and an associated method of implantation of the valve
US5266073A (en) 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
DE8815082U1 (en) 1988-11-29 1989-05-18 Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin Heart valve prosthesis
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4966604A (en) 1989-01-23 1990-10-30 Interventional Technologies Inc. Expandable atherectomy cutter with flexibly bowed blades
US4994077A (en) 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
EP0474748B1 (en) 1989-05-31 1995-01-25 Baxter International Inc. Biological valvular prosthesis
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5047041A (en) 1989-08-22 1991-09-10 Samuels Peter B Surgical apparatus for the excision of vein valves in situ
US4986830A (en) 1989-09-22 1991-01-22 Schneider (U.S.A.) Inc. Valvuloplasty catheter with balloon which remains stable during inflation
US5089015A (en) 1989-11-28 1992-02-18 Promedica International Method for implanting unstented xenografts and allografts
US5591185A (en) 1989-12-14 1997-01-07 Corneal Contouring Development L.L.C. Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping
US5037434A (en) 1990-04-11 1991-08-06 Carbomedics, Inc. Bioprosthetic heart valve with elastic commissures
US5059177A (en) 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
US5085635A (en) 1990-05-18 1992-02-04 Cragg Andrew H Valved-tip angiographic catheter
DK124690D0 (en) 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5152771A (en) 1990-12-31 1992-10-06 The Board Of Supervisors Of Louisiana State University Valve cutter for arterial by-pass surgery
US5282847A (en) 1991-02-28 1994-02-01 Medtronic, Inc. Prosthetic vascular grafts with a pleated structure
JPH05184611A (en) 1991-03-19 1993-07-27 Kenji Kusuhara Valvular annulation retaining member and its attaching method
US5295958A (en) 1991-04-04 1994-03-22 Shturman Cardiology Systems, Inc. Method and apparatus for in vivo heart valve decalcification
US5167628A (en) 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5397351A (en) 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
US5769812A (en) 1991-07-16 1998-06-23 Heartport, Inc. System for cardiac procedures
US5584803A (en) 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5558644A (en) 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5192297A (en) 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5756476A (en) 1992-01-14 1998-05-26 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell proliferation using antisense oligonucleotides
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US5628792A (en) 1992-03-13 1997-05-13 Jcl Technic Ab Cardiac valve with recessed valve flap hinges
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
DE4327825C2 (en) 1992-11-24 1996-10-02 Mannesmann Ag Throttle check element
US6346074B1 (en) 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
GB9312666D0 (en) 1993-06-18 1993-08-04 Vesely Ivan Bioprostetic heart valve
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5728068A (en) 1994-06-14 1998-03-17 Cordis Corporation Multi-purpose balloon catheter
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
US5639274A (en) 1995-06-02 1997-06-17 Fischell; Robert E. Integrated catheter system for balloon angioplasty and stent delivery
US5716417A (en) 1995-06-07 1998-02-10 St. Jude Medical, Inc. Integral supporting structure for bioprosthetic heart valve
US5571175A (en) 1995-06-07 1996-11-05 St. Jude Medical, Inc. Suture guard for prosthetic heart valve
DE19532846A1 (en) 1995-09-06 1997-03-13 Georg Dr Berg Valve for use in heart
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
DE19546692C2 (en) 1995-12-14 2002-11-07 Hans-Reiner Figulla Self-expanding heart valve prosthesis for implantation in the human body via a catheter system
FR2742994B1 (en) 1995-12-28 1998-04-03 Sgro Jean-Claude INTRACORPOREAL LIGHT SURGICAL TREATMENT ASSEMBLY
US5855602A (en) 1996-09-09 1999-01-05 Shelhigh, Inc. Heart valve prosthesis
DE69719237T2 (en) 1996-05-23 2003-11-27 Samsung Electronics Co., Ltd. Flexible, self-expandable stent and method for its manufacture
US5855601A (en) 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6217585B1 (en) 1996-08-16 2001-04-17 Converge Medical, Inc. Mechanical stent and graft delivery system
US5749890A (en) 1996-12-03 1998-05-12 Shaknovich; Alexander Method and system for stent placement in ostial lesions
NL1004827C2 (en) 1996-12-18 1998-06-19 Surgical Innovations Vof Device for regulating blood circulation.
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
GB9701479D0 (en) 1997-01-24 1997-03-12 Aortech Europ Ltd Heart valve
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6206917B1 (en) 1997-05-02 2001-03-27 St. Jude Medical, Inc. Differential treatment of prosthetic devices
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5925063A (en) 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
US6769161B2 (en) 1997-10-16 2004-08-03 Scimed Life Systems, Inc. Radial stent crimper
US5910170A (en) 1997-12-17 1999-06-08 St. Jude Medical, Inc. Prosthetic heart valve stent utilizing mounting clips
JP2002518066A (en) 1997-12-29 2002-06-25 ザ クリーブランド クリニック ファウンデーション System for inserting bioprosthetic heart valves with minimal invasion
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US6174327B1 (en) 1998-02-27 2001-01-16 Scimed Life Systems, Inc. Stent deployment apparatus and method
US6527979B2 (en) 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6165183A (en) * 1998-07-15 2000-12-26 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6334873B1 (en) 1998-09-28 2002-01-01 Autogenics Heart valve having tissue retention with anchors and an outer sheath
DE19857887B4 (en) 1998-12-15 2005-05-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring support for a heart valve prosthesis
SG76636A1 (en) 1998-12-22 2000-11-21 Medinol Ltd Apparatus and method for securing a stent on a balloon
FR2788217A1 (en) 1999-01-12 2000-07-13 Brice Letac PROSTHETIC VALVE IMPLANTABLE BY CATHETERISM, OR SURGICAL
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
BR0007745B1 (en) 1999-01-26 2009-01-13 Flexible heart valve.
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
DE19907646A1 (en) 1999-02-23 2000-08-24 Georg Berg Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire.
US6210408B1 (en) 1999-02-24 2001-04-03 Scimed Life Systems, Inc. Guide wire system for RF recanalization of vascular blockages
US6231602B1 (en) 1999-04-16 2001-05-15 Edwards Lifesciences Corporation Aortic annuloplasty ring
JP2002541974A (en) 1999-04-28 2002-12-10 セント・ジュード・メディカル・インコーポレーテッド Heart substitute valve
EP1057460A1 (en) 1999-06-01 2000-12-06 Numed, Inc. Replacement valve assembly and method of implanting same
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US6352547B1 (en) 1999-09-22 2002-03-05 Scimed Life Systems, Inc. Stent crimping system
IT1307268B1 (en) 1999-09-30 2001-10-30 Sorin Biomedica Cardio Spa DEVICE FOR HEART VALVE REPAIR OR REPLACEMENT.
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
FR2815844B1 (en) 2000-10-31 2003-01-17 Jacques Seguin TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE
DE19955490A1 (en) 1999-11-18 2001-06-13 Thermamed Gmbh Medical heating device
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
PL199785B1 (en) 2000-01-27 2008-10-31 3F Therapeutics Prosthetic heart valve
AU784782B2 (en) 2000-01-31 2006-06-15 Cook Biotech, Incorporated Stent valves and uses of same
DE10010073B4 (en) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring for implantable heart valve prostheses
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
WO2002022054A1 (en) 2000-09-12 2002-03-21 Gabbay S Valvular prosthesis and method of using same
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
DE10047614C2 (en) 2000-09-26 2003-03-27 Generis Gmbh Device for building up models in layers
DE10049812B4 (en) 2000-10-09 2004-06-03 Universitätsklinikum Freiburg Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart
DE10049815B4 (en) 2000-10-09 2005-10-13 Universitätsklinikum Freiburg Device for local ablation of an aortic valve on the human or animal heart
DE10049814B4 (en) 2000-10-09 2006-10-19 Universitätsklinikum Freiburg Device for supporting surgical procedures within a vessel, in particular for minimally invasive explantation and implantation of heart valves
DE10049813C1 (en) 2000-10-09 2002-04-18 Universitaetsklinikum Freiburg Instrument for the local removal of built-up matter at an aortic valve, in a human or animal heart, is a hollow catheter with a cutting unit at the far end within a closure cap for minimum invasion
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
WO2002041789A2 (en) 2000-11-21 2002-05-30 Rex Medical, L.P. Percutaneous aortic valve
US6440764B1 (en) 2000-11-22 2002-08-27 Agere Systems Guardian Corp. Enhancement of carrier concentration in As-containing contact layers
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
ES2253325T3 (en) 2000-12-15 2006-06-01 ANGIOMED GMBH & CO. MEDIZINTECHNIK KG ENDOVASCULAR PROTESIS WITH VALVE.
US6716244B2 (en) 2000-12-20 2004-04-06 Carbomedics, Inc. Sewing cuff assembly for heart valves
US6468660B2 (en) 2000-12-29 2002-10-22 St. Jude Medical, Inc. Biocompatible adhesives
US6783542B2 (en) 2001-02-22 2004-08-31 Scimed Life Systems, Inc Crimpable balloon/stent protector
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
US6503272B2 (en) 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US7374571B2 (en) 2001-03-23 2008-05-20 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of manufacture
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
DE60209583T2 (en) 2001-03-30 2006-12-21 Terumo K.K. stent
CA2445994A1 (en) 2001-05-01 2002-11-07 Asghar Khaghani Valve prosthesis
US6936067B2 (en) 2001-05-17 2005-08-30 St. Jude Medical Inc. Prosthetic heart valve with slit stent
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
AU2002347579A1 (en) 2001-11-23 2003-06-10 Mindguard Ltd. Expandable delivery appliance particularly for delivering intravascular devices
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7141064B2 (en) 2002-05-08 2006-11-28 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
US20040024452A1 (en) 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US6878162B2 (en) 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US7137184B2 (en) 2002-09-20 2006-11-21 Edwards Lifesciences Corporation Continuous heart valve support frame and method of manufacture
US7316710B1 (en) 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
US7096554B2 (en) 2003-04-04 2006-08-29 Boston Scientific Scimed, Inc. Protective loading of stents
WO2004096100A1 (en) 2003-04-24 2004-11-11 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
EP1635736A2 (en) 2003-06-05 2006-03-22 FlowMedica, Inc. Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens
US7959665B2 (en) 2003-07-31 2011-06-14 Abbott Cardiovascular Systems Inc. Intravascular stent with inverted end rings
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US20060259137A1 (en) 2003-10-06 2006-11-16 Jason Artof Minimally invasive valve replacement system
US20050075718A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
JP2007512919A (en) 2003-12-04 2007-05-24 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド Aortic annuloplasty ring
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
WO2005076973A2 (en) 2004-02-05 2005-08-25 Children's Medical Center Corporation Transcatheter delivery of a replacement heart valve
US7225518B2 (en) 2004-02-23 2007-06-05 Boston Scientific Scimed, Inc. Apparatus for crimping a stent assembly
US7207204B2 (en) 2004-02-26 2007-04-24 Boston Scientific Scimed, Inc. Crimper
CA2813136A1 (en) 2004-02-27 2005-09-15 Aortx, Inc. Prosthetic heart valve delivery systems and methods
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
US8979922B2 (en) 2004-03-11 2015-03-17 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
EP1753374A4 (en) 2004-04-23 2010-02-10 3F Therapeutics Inc Implantable prosthetic valve
PL1768630T3 (en) 2004-06-16 2015-07-31 Machine Solutions Inc Stent crimping device
US7276078B2 (en) 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
WO2006032051A2 (en) 2004-09-14 2006-03-23 Edwards Lifesciences Ag Device and method for treatment of heart valve regurgitation
CA3050938C (en) 2004-10-02 2021-10-19 Edwards Lifesciences Cardiaq Llc Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support
US7316148B2 (en) 2005-02-15 2008-01-08 Boston Scientific Scimed, Inc. Protective sheet loader
US8062359B2 (en) 2005-04-06 2011-11-22 Edwards Lifesciences Corporation Highly flexible heart valve connecting band
SE531468C2 (en) 2005-04-21 2009-04-14 Edwards Lifesciences Ag An apparatus for controlling blood flow
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
JP4912395B2 (en) 2005-05-24 2012-04-11 エドワーズ ライフサイエンシーズ コーポレイション Rapid placement prosthetic heart valve
US7681430B2 (en) 2005-05-25 2010-03-23 Boston Scientific Scimed, Inc. Method and apparatus for reducing a stent
US7238200B2 (en) 2005-06-03 2007-07-03 Arbor Surgical Technologies, Inc. Apparatus and methods for making leaflets and valve prostheses including such leaflets
US7780723B2 (en) 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US20080058856A1 (en) 2005-06-28 2008-03-06 Venkatesh Ramaiah Non-occluding dilation device
US8167932B2 (en) 2005-10-18 2012-05-01 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US8778017B2 (en) 2005-10-26 2014-07-15 Cardiosolutions, Inc. Safety for mitral valve implant
US7785366B2 (en) 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
WO2007067942A1 (en) 2005-12-07 2007-06-14 Arbor Surgical Technologies, Inc. Connection systems for two piece prosthetic heart valve assemblies
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
EP1988851A2 (en) 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US8147541B2 (en) 2006-02-27 2012-04-03 Aortx, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
US8219229B2 (en) 2006-03-02 2012-07-10 Edwards Lifesciences Corporation Virtual heart valve
WO2007123658A1 (en) 2006-03-28 2007-11-01 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
JP5016667B2 (en) 2006-04-29 2012-09-05 メドトロニック,インコーポレイテッド Multi-membered prosthetic heart valve assembly, apparatus using the same, and method of using the same
US20080021546A1 (en) 2006-07-18 2008-01-24 Tim Patz System for deploying balloon-expandable heart valves
WO2008015257A2 (en) 2006-08-02 2008-02-07 Syntach Ag Luminal implant with large expansion ratio
US8435617B2 (en) * 2006-08-17 2013-05-07 W. L. Gore & Associates, Inc. Stitchless seam system for joining laminates
US8876895B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Valve fixation member having engagement arms
US8029556B2 (en) 2006-10-04 2011-10-04 Edwards Lifesciences Corporation Method and apparatus for reshaping a ventricle
US7655034B2 (en) 2006-11-14 2010-02-02 Medtronic Vascular, Inc. Stent-graft with anchoring pins
US7832251B2 (en) 2006-11-15 2010-11-16 Abbott Laboratories Patterned mold for medical device
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
EP2444031B1 (en) 2007-01-19 2015-07-15 Medtronic, Inc. Stent delivery device
US20100168844A1 (en) 2007-01-26 2010-07-01 3F Therapeutics, Inc. Methods and systems for reducing paravalvular leakage in heart valves
US20080183271A1 (en) 2007-01-31 2008-07-31 Abbott Laboratories Compliant crimping sheath
US20080208327A1 (en) 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8002817B2 (en) 2007-05-04 2011-08-23 Abbott Cardiovascular Systems Inc. Stents with high radial strength and methods of manufacturing same
US20080294248A1 (en) 2007-05-25 2008-11-27 Medical Entrepreneurs Ii, Inc. Prosthetic Heart Valve
US9572660B2 (en) 2007-06-04 2017-02-21 St. Jude Medical, Inc. Prosthetic heart valves
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2192875B1 (en) 2007-08-24 2012-05-02 St. Jude Medical, Inc. Prosthetic aortic heart valves
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
ES2571740T3 (en) 2007-09-26 2016-05-26 St Jude Medical Collapsible prosthetic heart valves
BRPI0819217B8 (en) 2007-10-25 2021-06-22 Symetis Sa replacement valve for use within a human body, system for replacing a valve within a human body, and heart valve release system with stent
US8597349B2 (en) 2007-11-05 2013-12-03 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with non-expanding stent posts and retrieval features
WO2009084027A2 (en) * 2007-12-06 2009-07-09 Valikapathalil Mathew Kurian An implantable mechanical heart valve assembly
EP4079261B1 (en) 2007-12-14 2025-05-21 Edwards Lifesciences Corporation Leaflet attachment frame for a prosthetic valve
MX2010008171A (en) 2008-01-24 2010-12-07 Medtronic Inc Stents for prosthetic heart valves.
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
AU2009236062A1 (en) 2008-04-18 2009-10-22 Cook Medical Technologies Llc Branched vessel prosthesis
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US9061119B2 (en) 2008-05-09 2015-06-23 Edwards Lifesciences Corporation Low profile delivery system for transcatheter heart valve
ATE554731T1 (en) 2008-05-16 2012-05-15 Sorin Biomedica Cardio Srl ATRAAUMATIC PROSTHETIC HEART VALVE PROSTHESIS
US8291570B2 (en) 2008-05-30 2012-10-23 Boston Scientific Scimed, Inc. Methods for abluminally coating medical devices
EP3476367B2 (en) 2008-06-06 2024-11-20 Edwards Lifesciences Corporation Low profile transcatheter heart valve
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
ES2616743T3 (en) 2008-07-15 2017-06-14 St. Jude Medical, Llc Collapsible and re-expandable prosthetic heart valve sleeve designs and complementary technological applications
AU2009274131B2 (en) 2008-07-21 2015-06-04 Jennifer K. White Repositionable endoluminal support structure and its applications
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
EP4541320A3 (en) 2008-09-29 2025-07-09 Edwards Lifesciences CardiAQ LLC Heart valve
EP2358297B1 (en) 2008-11-21 2019-09-11 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis
CA2961053C (en) 2009-04-15 2019-04-30 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8075611B2 (en) 2009-06-02 2011-12-13 Medtronic, Inc. Stented prosthetic heart valves
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
EP2448522A4 (en) 2009-07-02 2018-01-31 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US8475522B2 (en) 2009-07-14 2013-07-02 Edwards Lifesciences Corporation Transapical delivery system for heart valves
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
WO2012040655A2 (en) 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
CN105380730B (en) 2010-10-05 2018-08-17 爱德华兹生命科学公司 Heart valve prosthesis
ES2781788T5 (en) 2010-10-05 2025-08-11 Edwards Lifesciences Corp Prosthetic heart valve
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US8945209B2 (en) 2011-05-20 2015-02-03 Edwards Lifesciences Corporation Encapsulated heart valve
US8795357B2 (en) 2011-07-15 2014-08-05 Edwards Lifesciences Corporation Perivalvular sealing for transcatheter heart valve
US9119716B2 (en) 2011-07-27 2015-09-01 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
US20130331929A1 (en) 2011-09-09 2013-12-12 Endoluminal Sciences Pty Ltd. Means for Controlled Sealing of Endovascular Devices
US9216076B2 (en) * 2011-09-09 2015-12-22 Endoluminal Sciences Pty. Ltd. Means for controlled sealing of endovascular devices
US20130190857A1 (en) 2011-09-09 2013-07-25 Endoluminal Sciences Pty Ltd. Means for controlled sealing of endovascular devices
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP4049626A1 (en) 2011-12-09 2022-08-31 Edwards Lifesciences Corporation Prosthetic heart valve having improved commissure supports
WO2013106585A1 (en) 2012-01-10 2013-07-18 White Jennifer K Articulated support structure with secondary strut features
US20130274873A1 (en) 2012-03-22 2013-10-17 Symetis Sa Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage
US9132007B2 (en) 2013-01-10 2015-09-15 Medtronic CV Luxembourg S.a.r.l. Anti-paravalvular leakage components for a transcatheter valve prosthesis
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
EP2967869B1 (en) * 2013-03-12 2018-01-31 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US8986375B2 (en) 2013-03-12 2015-03-24 Medtronic, Inc. Anti-paravalvular leakage component for a transcatheter valve prosthesis
US9636222B2 (en) 2013-03-12 2017-05-02 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak protection
SG10201707038RA (en) 2013-03-13 2017-09-28 Jenesis Surgical Llc Articulated commissure valve stents and methods
US9326856B2 (en) 2013-03-14 2016-05-03 St. Jude Medical, Cardiology Division, Inc. Cuff configurations for prosthetic heart valve
US9486306B2 (en) * 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
JP2016517748A (en) 2013-05-03 2016-06-20 メドトロニック,インコーポレイテッド Medical device and related methods for implantation in a valve
CN105188612B (en) 2013-05-20 2017-08-08 爱德华兹生命科学公司 Prosthetic Heart Valve Delivery Device
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
WO2015038458A1 (en) 2013-09-12 2015-03-19 St. Jude Medical, Cardiology Division, Inc. Stent designs for prosthetic heart valves
CN111419472B (en) 2013-11-11 2023-01-10 爱德华兹生命科学卡迪尔克有限责任公司 System and method for manufacturing stent frames
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
CN103690272B (en) * 2014-01-15 2016-08-17 梁宏亮 Expanding petal skirt aorta mechanical valve prosthesis
US9693860B2 (en) * 2014-12-01 2017-07-04 Medtronic, Inc. Segmented transcatheter valve prosthesis having an unsupported valve segment
US9579195B2 (en) 2015-01-13 2017-02-28 Horizon Scientific Corp. Mitral bileaflet valve
US9974650B2 (en) 2015-07-14 2018-05-22 Edwards Lifesciences Corporation Prosthetic heart valve
US10179043B2 (en) * 2016-02-12 2019-01-15 Edwards Lifesciences Corporation Prosthetic heart valve having multi-level sealing member
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
US10603165B2 (en) 2016-12-06 2020-03-31 Edwards Lifesciences Corporation Mechanically expanding heart valve and delivery apparatus therefor
US11135056B2 (en) 2017-05-15 2021-10-05 Edwards Lifesciences Corporation Devices and methods of commissure formation for prosthetic heart valve
US10869759B2 (en) 2017-06-05 2020-12-22 Edwards Lifesciences Corporation Mechanically expandable heart valve
CN208770070U (en) * 2017-11-07 2019-04-23 先健科技(深圳)有限公司 Heart valve anchoring device and heart valve

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022124A1 (en) * 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
CN105324091A (en) * 2014-05-12 2016-02-10 爱德华兹生命科学公司 prosthetic heart valve

Also Published As

Publication number Publication date
KR102619515B1 (en) 2023-12-28
EP3672528B1 (en) 2021-09-22
CN111163730A (en) 2020-05-15
CA3072239A1 (en) 2019-02-28
US20240122702A1 (en) 2024-04-18
US10722353B2 (en) 2020-07-28
KR20200035160A (en) 2020-04-01
EP3964174B1 (en) 2025-02-12
EP4591829A2 (en) 2025-07-30
US11850148B2 (en) 2023-12-26
CN111163730B (en) 2021-10-01
US20190053899A1 (en) 2019-02-21
WO2019040364A1 (en) 2019-02-28
US20200345488A1 (en) 2020-11-05
EP4591829A3 (en) 2025-10-22
EP3672528A4 (en) 2020-08-26
CN113730033A (en) 2021-12-03
EP3964174A1 (en) 2022-03-09
ES2900642T3 (en) 2022-03-17
DK3672528T3 (en) 2021-11-15
EP3672528A1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
CN113730033B (en) Sealing member for prosthetic heart valve
CN111050700B (en) Sealing member for artificial heart valve
US12076235B2 (en) Prosthetic heart valve
US20240358498A1 (en) Sealing member for prosthetic heart valve
CN111148487B (en) Sealing elements for prosthetic heart valves
CN113795222B (en) Sealing elements for prosthetic heart valves
HK40082301A (en) Sealing members for prosthetic heart valve
HK40028668A (en) Sealing member for prosthetic heart valve

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant